Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model

Nanotoxicology

Volumn 5, Issue 4, 2011, Pages 459-468

  Glazer, Evan S ^a   Zhu, Cihui ^a   Hamir, Amir N ^a   Borne, Agatha ^a   Thompson, Catherine Shea ^a,b   Curley, Steven A ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b RICE UNIVERSITY   (United States)

^c Rice University   (United States)

Author keywords

Acute toxicity; Biodistribution; Gold nanoparticle; Tumor model

Indexed keywords

GOLD NANOPARTICLE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG URINE LEVEL; LEUKOCYTE COUNT; LIVER; LIVER TUMOR; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPLEEN; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BLOOD CELL COUNT; GOLD; HISTOCYTOCHEMISTRY; INJECTIONS, INTRAVENOUS; LIVER NEOPLASMS, EXPERIMENTAL; MASS SPECTROMETRY; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; RABBITS; TISSUE DISTRIBUTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 80655145977     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2010.516026     Document Type: Article

References (25)

1. Antonovych TT. 1981. Gold nephropathy. Ann Clin Lab Sci 11(5):386-391. (Pubitemid 11057309)
2. Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY. 2009. Toxicity assessments of multisized gold and silver nanoparticles in zebra-fish embryos. Small 5(16):1897-910.
3. Cherukuri P, Glazer ES, Curley SA. 2009. Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev 62(3):339-345.
4. Chien AJ, Illi JA, Ko AH, Kom WM, Fong L, Chen LM, et al. 2009. A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies. Clin Cancer Res 15(17): 5569-5575.
5. Chithrani BD, Ghazani AA, Chan WC. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6(4):662-668.
6. Curley SA, Cherukuri P, Briggs K, Patra CR, Upton M, Dolson Eet al. 2008. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuxi-mab-targeted gold nanoparticles. J Exp Ther Oncol 7(4): 313-326.
7. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. 2008. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Bioma-terials 29(12):1912-1919.
8. Decuzzi P, Ferrari M. 2008. The receptor-mediated endocytosis of nonspherical particles. Biophys J 94(10):3790-3797.
9. Dhar S, Daniel WL, Giljohann DA, Mirkin CA, Lippard SJ. 2009. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. J Am Chem Soc 131 (41):14652-14653.
10. Finkelstein AE, Walz DT, Batista V, Mizraji M, Roisman F, Misher A. 1976. Auranofin. New oral gold compound for treatment of rheumatoid arthritis. Ann Rheum Dis 35(3):251-257.
11. Gannon CJ, Cherukuri P, Yakobson BI, Cognet L, Kanzius JS, Kittrell C, et al. 2007. Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer 110(12):2654-2665. (Pubitemid 350250334)
12. Glazer ES, Curley SA. 2010. Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparti-cles. Cancer 116(13):3285-3293.
13. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al. 2000. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156(4):1363-1380. (Pubitemid 30660013)
14. Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, et al. 2002. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 8(5): 1038-1044. (Pubitemid 34517637)
15. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40(4):328-346.
16. Lasagna-Reeves C, Gonzalez-Romero D, et al. 2010. Bioaccumu-lation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 393(4): 649-655.
17. Luo W, Zhou X, Zheng X, He G, Yu M, Li Q, et al. 2009. Role of sonography for implantation and sequential evaluation of a VX2 rabbit liver tumor model. J Ultrasound Med 29(1):51-60.
18. Milacic V, Fregona D, Dou QP. 2008. Gold complexes as prospective metal-based anticancer drugs. Histol Histopathol 23(1): 101-108.
19. Sadauskas E, Danscher G, Stoltenberg M, Vogel D, Larsen A, Wallin H. 2009. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 5(2):162-169.
20. Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, Larsen A, et al. 2007. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4:10.
21. Shope RE, Hurst EW. 1933. Infectious papillomatosis of rabbits: With a note on the histopathology. J Exp Med 58(5): 607-624.
22. Sonavane G, Tomoda K, Makino K. 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids Surf B Biointerfaces 66(2): 274-280.
23. Sukumar M, Doyle BL, Combs JL, Pekar AH. 2004. Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association. Pharm Res 21(7): 1087-1093. (Pubitemid 38954191)
24. Trouiller B, Reliene R, Westbrook A, Solaimani P, Schiestl RH. 2009. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res 69(22):8784-8789.
25. Wust P, Gneveckow U, Johannsen M, Bohmer D, Henkel T, Kahmann F, et al. 2006. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int J Hyperthermia 22(8):673-685. (Pubitemid 46332053)